Hikma Pharmaceuticals Saudi Arabia

GPTKB entity

Statements (49)
Predicate Object
gptkbp:instanceOf gptkb:Company
gptkbp:acquisition gptkb:Merck_Generics
gptkb:Roxane_Laboratories
gptkbp:CEO gptkb:Khaled_Abouzaid
gptkbp:employeeCount Over 7,000
gptkbp:focus Gastroenterology
Health education
Oncology
Pain management
Respiratory diseases
Urology
Clinical trials
Diabetes
Neurology
Ophthalmology
Cardiovascular diseases
Infectious diseases
Pediatrics
Corporate social responsibility
Vaccines
Dermatology
Sustainability initiatives
Chronic diseases
Patient support programs
Biologics
Nutraceuticals
Biosimilars
Women’s health
Men’s health
OTC products
Cosmeceuticals
gptkbp:founded 1978
gptkbp:founder gptkb:Samir_Aboulatta
gptkbp:headquarters gptkb:Saudi_Arabia
https://www.w3.org/2000/01/rdf-schema#label Hikma Pharmaceuticals Saudi Arabia
gptkbp:industry Pharmaceuticals
gptkbp:market gptkb:North_Africa
gptkb:United_States
Middle_East
gptkbp:partnerships Various healthcare organizations
gptkbp:products Branded medications
Generic_medications
gptkbp:regulatoryCompliance gptkb:FDA
EMA
gptkbp:researchAndDevelopment Yes
gptkbp:revenue $1.5 billion (2020)
gptkbp:services Contract manufacturing
gptkbp:subsidiary gptkb:Hikma_Pharmaceuticals_PLC
gptkbp:website www.hikma.com